On August 29, 2018 Aptose Biosciences Inc. (NASDAQ: APTO, TSX: APS), a clinical-stage company developing highly differentiated therapeutics targeting the underlying mechanisms of cancer, reported that William G. Rice, Chairman, Ph.D., President and Chief Executive Officer, and Gregory K. Chow, Senior Vice President and Chief Financial Officer, will participate at upcoming conferences (Press release, Aptose Biosciences, AUG 29, 2018, View Source [SID1234529350]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

B. Riley FBR Annual Healthcare Conference
Date: Tuesday, September 4, 2018
Location: New York Marriott East Side

Dr. Rice will be participating on two panels:
9:50 a.m. EDT – A Beginner’s Guide to Blood Cancers
3:25 p.m. EDT – Immuno-oncology Has Made TKIs Obsolete

H.C. Wainwright & Co. 20th Annual Global Investment Conference
Date: Wednesday, September 5, 2018
Time: 8:45 a.m. EDT
Location: The St. Regis New York
Live webcast: Webcast Link
2018 Healthcare Capital and Connections Summit
Date: September 12-13, 2018
Location: Andaz Xintiandi, Shanghai, People’s Republic of China